Apellis Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/27/2026 | 637 | 0.0% | 25,364 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 482 | 0.0% | 21,317 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 331 | 0.0% | 19,128 | 6/30/2025 |
| 2025 Q1 | 5/7/2025 | 435 | 0.0% | 19,891 | 3/31/2025 |
| 2024 Q4 | 2/7/2025 | 649 | 0.0% | 20,348 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 554 | 0.0% | 19,212 | 9/30/2024 |
| 2024 Q2 | 7/29/2024 | 752 | 0.0% | 19,614 | 6/30/2024 |
| 2024 Q1 | 4/25/2024 | 998 | 0.0% | 16,979 | 3/31/2024 |
| 2023 Q4 | 1/30/2024 | 1,205 | 0.0% | 20,123 | 12/31/2023 |
| 2023 Q3 | 10/25/2023 | 533 | 0.0% | 14,021 | 9/30/2023 |
| 2023 Q2 | 8/7/2023 | 1,158 | 0.0% | 12,711 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 769 | 0.0% | 11,661 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 550 | 0.0% | 10,635 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 786 | 0.0% | 11,515 | 9/30/2022 |
| 2022 Q2 | 8/9/2022 | 471 | 0.0% | 10,408 | 6/30/2022 |
| 2022 Q1 | 4/21/2022 | 591 | 0.0% | 11,627 | 3/31/2022 |
| 2021 Q4 | 2/1/2022 | 646 | 0.0% | 13,669 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 241 | 0.0% | 7,316 | 9/30/2021 |
| 2021 Q2 | 7/30/2021 | 462 | 0.0% | 7,303 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 310 | 0.0% | 7,221 | 3/31/2021 |
| 2020 Q4 | 1/28/2021 | 465 | 0.0% | 8,126 | 12/31/2020 |
| 2020 Q3 | 11/6/2020 | 245 | 0.0% | 8,126 | 9/30/2020 |
| 2020 Q2 | 7/28/2020 | 265 | 0.0% | 8,126 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 127 | 0.0% | 4,741 | 3/31/2020 |
| 2019 Q4 | 1/21/2020 | 124 | 0.0% | 4,041 | 12/31/2019 |